0 avis
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers
Archive ouverte
Edité par CCSD ; Cell Press -
International audience. Highlights d Relapsed rhabdomyosarcoma (RMS) 3D organoids can be derived from needle biopsies d RMS 3D organoids finely preserve inter-and intra-tumor heterogeneity d Transcriptomic approach reveals Survivin as a key apoptosis blockage point in RMS d RMS 3D organoids are powerful tools to design and/or reexplore drug combinations Authors